Larry House

772 total citations
30 papers, 604 citations indexed

About

Larry House is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Larry House has authored 30 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Pharmacology. Recurrent topics in Larry House's work include Cancer therapeutics and mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Lung Cancer Research Studies (6 papers). Larry House is often cited by papers focused on Cancer therapeutics and mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Lung Cancer Research Studies (6 papers). Larry House collaborates with scholars based in United States, China and Hong Kong. Larry House's co-authors include Mark J. Ratain, Jacqueline Ramı́rez, Kehua Wu, Yong Liu, Samir D. Undevia, Wanqing Liu, Federico Innocenti, Linda Janisch, Michael L. Maitland and Theodore Karrison and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Larry House

28 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry House United States 12 330 252 112 112 86 30 604
Valérie Le Morvan France 18 389 1.2× 310 1.2× 113 1.0× 124 1.1× 129 1.5× 45 745
Erin R. Lepper United States 11 291 0.9× 384 1.5× 120 1.1× 122 1.1× 36 0.4× 12 695
Benny Amore United States 17 258 0.8× 278 1.1× 142 1.3× 103 0.9× 53 0.6× 33 927
Yuzhuo Pan United States 13 348 1.1× 260 1.0× 161 1.4× 153 1.4× 181 2.1× 27 845
Georgina Meneses‐Lorente United Kingdom 17 340 1.0× 260 1.0× 90 0.8× 120 1.1× 60 0.7× 51 843
Margaret Kindlen United States 8 478 1.4× 269 1.1× 92 0.8× 117 1.0× 53 0.6× 11 842
Dennis A. Noe United States 16 333 1.0× 256 1.0× 69 0.6× 46 0.4× 55 0.6× 32 871
Karsten Denner Germany 11 323 1.0× 108 0.4× 93 0.8× 169 1.5× 56 0.7× 19 660
R J van Alphen Netherlands 5 549 1.7× 535 2.1× 103 0.9× 91 0.8× 47 0.5× 6 860
E. Boven Netherlands 11 308 0.9× 503 2.0× 116 1.0× 57 0.5× 63 0.7× 25 770

Countries citing papers authored by Larry House

Since Specialization
Citations

This map shows the geographic impact of Larry House's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry House with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry House more than expected).

Fields of papers citing papers by Larry House

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry House. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry House. The network helps show where Larry House may publish in the future.

Co-authorship network of co-authors of Larry House

This figure shows the co-authorship network connecting the top 25 collaborators of Larry House. A scholar is included among the top collaborators of Larry House based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry House. Larry House is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Leary, Kevin J., Edith A. Nutescu, Tai C. Chen, et al.. (2025). Results of the ACCOuNT Trial: A Multi‐Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients. Clinical Pharmacology & Therapeutics. 119(1). 109–119. 1 indexed citations
2.
O’Leary, Kevin J., Edith A. Nutescu, Tai C. Chen, et al.. (2025). Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient Prescribing. Clinical and Translational Science. 18(4). e70193–e70193. 1 indexed citations
3.
House, Larry, Michael J. Seminerio, Snezana Mirkov, et al.. (2017). Metabolism of megestrol acetate in vitro and the role of oxidative metabolites. Xenobiotica. 48(10). 973–983. 5 indexed citations
4.
House, Larry, Jacqueline Ramı́rez, Michael J. Seminerio, Snezana Mirkov, & Mark J. Ratain. (2015). In vitroglucuronidation of aprepitant: a moderate inhibitor of UGT2B7. Xenobiotica. 45(11). 990–998. 8 indexed citations
5.
Ramı́rez, Jacqueline, Snezana Mirkov, Larry House, & Mark J. Ratain. (2015). Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10. Drug Metabolism and Disposition. 43(7). 928–935. 12 indexed citations
6.
Wen, Yujia, Theodore Karrison, George L. Bakris, et al.. (2014). Sorafenib Dose Escalation Is Not Uniformly Associated With Blood Pressure Elevations in Normotensive Patients With Advanced Malignancies. Clinical Pharmacology & Therapeutics. 96(1). 27–35. 11 indexed citations
7.
Innocenti, Federico, Richard L. Schilsky, Jacqueline Ramı́rez, et al.. (2014). Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to the UGT1A1 Genotype of Patients With Cancer. Journal of Clinical Oncology. 32(22). 2328–2334. 105 indexed citations
8.
Wu, Kehua, Larry House, Jacqueline Ramı́rez, Michael J. Seminerio, & Mark J. Ratain. (2013). Evaluation of Utility of Pharmacokinetic Studies in Phase I Trials of Two Oncology Drugs. Clinical Cancer Research. 19(21). 6039–6043. 5 indexed citations
9.
Cohen, Ezra E.W., Kehua Wu, Christine Hartford, et al.. (2012). Phase I Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients. Clinical Cancer Research. 18(17). 4785–4793. 51 indexed citations
10.
Wu, Kehua, Larry House, Wanqing Liu, & Yong‐Yeon Cho. (2012). Personalized Targeted Therapy for Lung Cancer. International Journal of Molecular Sciences. 13(9). 11471–11496. 54 indexed citations
11.
Cohen, Ezra E.W., Manish Sharma, Linda Janisch, et al.. (2011). A phase I study of sirolimus and bevacizumab in patients with advanced malignancies. European Journal of Cancer. 47(10). 1484–1489. 20 indexed citations
12.
Gangadhar, Tara C., Ezra E.W. Cohen, Kehua Wu, et al.. (2011). Two Drug Interaction Studies of Sirolimus in Combination with Sorafenib or Sunitinib in Patients with Advanced Malignancies. Clinical Cancer Research. 17(7). 1956–1963. 38 indexed citations
13.
Ramı́rez, Jacqueline, Kehua Wu, Linda Janisch, et al.. (2011). The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients. Cancer Chemotherapy and Pharmacology. 68(6). 1629–1632. 6 indexed citations
14.
Kang, Soonmo Peter, Jacqueline Ramı́rez, Larry House, et al.. (2010). A pharmacogenetic study of vorinostat glucuronidation. Pharmacogenetics and Genomics. 20(10). 638–641. 36 indexed citations
15.
Liu, Yong, Jacqueline Ramı́rez, Larry House, & Mark J. Ratain. (2010). The UGT1A1∗28 polymorphism correlates with erlotinib’s effect on SN-38 glucuronidation. European Journal of Cancer. 46(11). 2097–2103. 22 indexed citations
16.
Liu, Yong, Jacqueline Ramı́rez, Larry House, & Mark J. Ratain. (2009). Comparison of the Drug-Drug Interactions Potential of Erlotinib and Gefitinib via Inhibition of UDP-Glucuronosyltransferases. Drug Metabolism and Disposition. 38(1). 32–39. 90 indexed citations
17.
Undevia, Samir D., Federico Innocenti, Jacqueline Ramı́rez, et al.. (2008). A phase I and pharmacokinetic study of the quinoxaline antitumour Agent R(+)XK469 in patients with advanced solid tumours. European Journal of Cancer. 44(12). 1684–1692. 54 indexed citations
18.
Gangadhar, Tara C., Ezra E.W. Cohen, Linda Janisch, et al.. (2008). A drug interaction study of sorafenib (S) and rapamycin (R) in patients with advanced malignancies. Journal of Clinical Oncology. 26(15_suppl). 2545–2545. 3 indexed citations
19.
Yong, Wei Peng, Apurva A. Desai, Federico Innocenti, et al.. (2007). Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 60(6). 811–819. 18 indexed citations
20.
Innocenti, Federico, et al.. (2003). CYP3A4, CYP3A5 and CYP2C9 Are Responsible For The N‐Demethylation of Meperidine to Normeperidine in Vitro. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valérie Le Morvan Breakdown of academic impact, for papers by Erin R. Lepper Breakdown of academic impact, for papers by Benny Amore Breakdown of academic impact, for papers by Yuzhuo Pan Breakdown of academic impact, for papers by Georgina Meneses‐Lorente Breakdown of academic impact, for papers by Margaret Kindlen Breakdown of academic impact, for papers by Dennis A. Noe Breakdown of academic impact, for papers by Karsten Denner Breakdown of academic impact, for papers by R J van Alphen Breakdown of academic impact, for papers by E. Boven
Rankless by CCL
2026